tradingkey.logo

Vsee Health Inc

VSEE

1.350USD

+0.140+11.56%
Market hours ETQuotes delayed by 15 min
20.74MMarket Cap
LossP/E TTM

Vsee Health Inc

1.350

+0.140+11.56%
More Details of Vsee Health Inc Company
VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.
Company Info
Ticker SymbolVSEE
Company nameVsee Health Inc
IPO dateNov 04, 2021
CEODr. Milton Chen, Ph.D.
Number of employees154
Security typeOrdinary Share
Fiscal year-endNov 04
Address980 N Federal Hwy
CityBOCA RATON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code33432
Phone15616727068
Websitehttps://vsee.com/
Ticker SymbolVSEE
IPO dateNov 04, 2021
CEODr. Milton Chen, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Imoigele Aisiku, M.D.
Dr. Imoigele Aisiku, M.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
3.42M
-3.39%
Dr. Milton Chen, Ph.D.
Dr. Milton Chen, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.87M
--
Dr. Scott Metzger
Dr. Scott Metzger
Independent Director
Independent Director
8.63K
--
Mr. Kevin Lowdermilk
Mr. Kevin Lowdermilk
Independent Director
Independent Director
--
--
Mr. David L. Wickersham
Mr. David L. Wickersham
Independent Director
Independent Director
--
--
Mr. Jerry Leonard
Mr. Jerry Leonard
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Colin O'Sullivan
Mr. Colin O'Sullivan
Director
Director
--
--
Ms. Cydonii V. Fairfax
Ms. Cydonii V. Fairfax
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Imoigele Aisiku, M.D.
Dr. Imoigele Aisiku, M.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
3.42M
-3.39%
Dr. Milton Chen, Ph.D.
Dr. Milton Chen, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.87M
--
Dr. Scott Metzger
Dr. Scott Metzger
Independent Director
Independent Director
8.63K
--
Mr. Kevin Lowdermilk
Mr. Kevin Lowdermilk
Independent Director
Independent Director
--
--
Mr. David L. Wickersham
Mr. David L. Wickersham
Independent Director
Independent Director
--
--
Mr. Jerry Leonard
Mr. Jerry Leonard
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jul 24
Updated: Thu, Jul 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Aisiku (Imoigele)
21.81%
Chen (Milton)
18.32%
Digital Health Sponsor LLC
16.79%
SCS Capital Management LLC
3.19%
Wickersham (David L.)
0.73%
Other
39.15%
Shareholders
Shareholders
Proportion
Aisiku (Imoigele)
21.81%
Chen (Milton)
18.32%
Digital Health Sponsor LLC
16.79%
SCS Capital Management LLC
3.19%
Wickersham (David L.)
0.73%
Other
39.15%
Shareholder Types
Shareholders
Proportion
Individual Investor
40.92%
Corporation
17.43%
Investment Advisor/Hedge Fund
3.84%
Investment Advisor
0.79%
Venture Capital
0.18%
Hedge Fund
0.13%
Other
36.71%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
31
9.91M
63.29%
-1.87M
2025Q1
31
10.50M
67.03%
-685.58K
2024Q4
28
9.85M
62.87%
-1.21M
2024Q3
61
10.11M
73.63%
-10.21M
2024Q2
59
10.44M
76.15%
-2.85M
2024Q1
65
3.46M
96.42%
-12.49M
2023Q4
66
3.44M
82.48%
-12.61M
2023Q3
66
4.08M
97.64%
-11.96M
2023Q2
66
4.08M
97.52%
-11.93M
2023Q1
66
4.05M
98.15%
-11.82M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Aisiku (Imoigele)
3.42M
21.81%
-120.00K
-3.39%
Nov 18, 2024
Chen (Milton)
2.87M
18.32%
--
--
Nov 18, 2024
Digital Health Sponsor LLC
2.63M
16.79%
--
--
Nov 18, 2024
SCS Capital Management LLC
500.00K
3.19%
--
--
Jun 24, 2024
Wickersham (David L.)
114.00K
0.73%
--
--
Nov 18, 2024
Dominion Capital LLC
100.00K
0.64%
-530.00K
-84.13%
Sep 30, 2024
UBS Financial Services, Inc.
90.15K
0.58%
+30.62K
+51.44%
Mar 31, 2025
Geode Capital Management, L.L.C.
76.45K
0.49%
+8.90K
+13.17%
Mar 31, 2025
XTX Markets LLC
28.63K
0.18%
+28.63K
--
Mar 31, 2025
State Street Global Advisors (US)
18.90K
0.12%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI